National Survey on Asthma (SYMPTOMES)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00770250
First received: October 7, 2008
Last updated: November 30, 2010
Last verified: November 2010

October 7, 2008
November 30, 2010
September 2008
Not Provided
The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control. [ Time Frame: Once ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00770250 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
National Survey on Asthma
A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine

To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample

The first 2 consecutive patients seen during the GP's visit with a diagnosis of persistent asthma

Asthma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1704
March 2009
Not Provided

Inclusion Criteria:

  • A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
  • Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.

Exclusion Criteria:

  • Patient with a cardiac disease (congestive heart failure, coronary artery disease)
  • Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00770250
NIS-RFR-DUM-2008/1
No
Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
AstraZeneca
Not Provided
Study Director: Alain Castaigne AstraZeneca
AstraZeneca
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP